The largest database of trusted experimental protocols

Phospho stat3

Manufactured by Santa Cruz Biotechnology
Sourced in United States

Phospho-STAT3 is a laboratory reagent used in immunoassays to detect and quantify the phosphorylated form of the STAT3 protein. STAT3 is a transcription factor that plays a key role in cellular signaling pathways. The phosphorylation of STAT3 is an important regulatory mechanism that can be studied using this product.

Automatically generated - may contain errors

21 protocols using phospho stat3

1

Quantifying Protein Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analysis was performed as described previously.15 (link),20 (link) The membrane containing transferred protein was incubated with the following primary antibodies overnight at 4°C: Rabbit polyclonal antibodies against signal transducer and activator of transcription 3 (STAT3; cat. no. sc-482; dilution, 1:400; Santa Cruz Biotechnology, Inc., Dallas, TX, USA), phospho (p)-STAT3 (cat. no. sc-8059; dilution, 1:500; Santa Cruz Biotechnology, Inc.), p65 (cat. no. sc-7151; dilution, 1:400; Santa Cruz Biotechnology, Inc.) and cyclooxygenase-2 (COX-2; cat. no. sc-23,983; dilution, 1:400; Santa Cruz Biotechnology, Inc.). Following washing with 0.1% Tween-20 in PBS, the membranes were then incubated with the following horseradish peroxidase-conjugated secondary antibodies for 1 h at 37°C: Goat anti-rabbit immunoglobulin G (IgG; cat. no. sc-2004; dilution, 1:2,000; Santa Cruz Biotechnology, Inc.). Proteins were detected using an enhanced chemiluminescence kit (GE Healthcare Life Sciences, Chalfont, UK). Anti-GAPDH monoclonal antibody (cat. no. ab9485; dilution, 1:2,500; Abcam, Cambridge, MA, USA) was used to ensure equal loading of protein.
+ Open protocol
+ Expand
2

Adipogenic Differentiation Pathway Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
DHA was bought from Selleckchem (Houston, TX, USA).
Primary antibodies of STAT-3, phospho (p)-STAT-3, STAT-5, p-STAT-5, C/EBP-α, and PPAR-γ were obtained from Santa Cruz Biotechnology (Delaware, CA, USA). Primary FAS antibody was bought from BD Bioscience (San Jose, CA, USA). Primary antibodies of perilipin A and β-actin were obtained from Bio Vision (Milpitas, CA, USA) and Sigma (St. Louis, MO, USA), respectively. Enhanced chemiluminescence (ECL) reagent was bought from Advansta (Menlo Park, CA, USA).
3-isobutyl-1-methylxanthine (IBMX), dexamethasone, and insulin were purchased from Sigma.
+ Open protocol
+ Expand
3

Evaluating ECFC-Derived Vascular Formation

Check if the same lab product or an alternative is used in the 5 most similar protocols
After 3 and 28 days following ECFC transplantation, the ischemic thigh areas were removed and fixed with 4 % paraformaldehyde (Affymetrix, Santa Clara, CA, USA). Each tissue sample was embedded in paraffin. For histological analysis, samples were stained with hematoxylin and eosin (H&E). Immunofluorescence staining was performed using primary antibodies against mouse-specific (to confirm mouse vasculature) or human-specific (to confirm human ECFC-derived vessel formation) CD31, α-smooth muscle actin (α-SMA), human VEGF, phospho-STAT3, caspase-3, PCNA, Ki67 (Santa Cruz), human-specific CD31 (Novus Biologicals, Colorado, USA), and human nuclear antigen (HNA; Millipore) and secondary antibodies Alexa-488 and Alexa-594 (Life Technologies, Carlsbad, CA, USA). Nuclei were stained with 4′,6-diamidino-2-phenylindole phenylindole (DAPI; Vector Laboratories, Burlingame, CA, USA). Immunostained slides were imaged by confocal microscopy (Olympus, Japan).
+ Open protocol
+ Expand
4

CXCL1 Signaling Pathway Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded in 6 well plates at 250,000/well for 24 hours, serum starved for 24 hours, and stimulated with 60 ng/ml mouse recombinant CXCL1 (RnD Systems) for up to 24 hours. Cells were lysed in RIPA buffer containing protease inhibitors (Sigma cat no. P8340) and 10 μM sodium orthovanadate and sonicated. 50 μg protein were resolved on 10% SDS-PAGE and transferred to nitrocellulose membranes. Blots were blocked in PBS containing 0.05% Tween-20 (PBS-T) containing 3% dry milk for 1 hour and immunoblotted with primary antibodies at a 1:1000 overnight in PBS-T/3% BSA. With the exception of FAK, antibodies were obtained from Cell Signaling Technology: phospho-Src (Tyr416 cat no. 6943), Src (cat no. 2123), phospho-FAK (Tyr397 cat no.8856), FAK (Santa Cruz Biotechnology, cat no. sc558), phospho-p38MAPK (Thr180/Tyr182, cat no. 4511), p38MAPK (cat no. 9212), phospho-IκB (Ser32/36, cat no. 9246), IκB (cat no. 2678), phospho-p42/44MAPK (Thr202/Tyr204, cat no. 9101), p42/44MAPK (cat no. 9102), phospho-AKT (Ser473, cat no. 4060), AKT (cat no. 2965), phospho-Stat3 (Tyr705, cat no. 9145), Stat3 (cat no. 9132). Immunoblots were washed in PBS-T 3 times for 10 minutes each and incubated with secondary anti-rabbit conjugated to horse radish peroxidase at a 1:1000 dilution in PBS-T/3% milk for 2 hours. Reactions were catalyzed with West Femto ECL substrate.
+ Open protocol
+ Expand
5

Western Blot Analysis of HepG2 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
HepG2 cells were lysed in RIPA buffer (Beyotime Institute of Biotechnology, Shanghai, China). Cell lysates (20 μg protein/lane) were loaded and separated on gradient polyacrylamide gels and then transferred to polyvinylidene difluoride membranes by electroblotting (Millipore Corp., Boston, MA, USA). Following blocking with 5% non-fat milk containing 0.3% Tween 20 for 1 h, the membranes were incubated overnight with primary antibodies at 4°C, including anti-hSulf-1 (1:250), -stat3 (1:500), -phospho-stat3 (1:500), -phospho-c-met (1:500), -bcl-2 (1:1000) and -cyclin D1 (1:500) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA). The membranes were washed three times with Tris-buffered saline containing Tween 20 and membranes were then incubated with horseradish peroxidase-conjugated secondary antibodies (R&D Systems China Co., Ltd., Shanghai, China) at 4°C for 1 h. Subsequently, membranes were exposed to enhanced chemiluminescent reagents for detection of protein bands. β-actin was used as an internal control.
+ Open protocol
+ Expand
6

Western Blot Analysis of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissues or cells were mechanically homogenized in ice-cold lysis buffer and centrifuged for 10 minutes at 4 °C and 14,000 g for tissues or 8,000 g for cells. The resulting supernatant fraction was separated by SDS-PAGE and immunoblotted with antibodies against phospho-AKT (S473; 1:1000), total AKT (1:1000), total JAK2 (1:1000), tubulin (1:1000), phospho-STAT3 (Y705, 1:2000), total STAT3 (1:1000), phospho-STAT5 (Y694, 1:1000), total STAT5 (1:1000), phospho-NF-κB p65 (Y694, 1:1000), total NF-κB p65 (1:1000), phospho-JNK (T183/Y185, 1:500, Santa Cruz Biotechnology) or total JNK1 (1:500, Santa Cruz Biotechnology) or GAPDH (1:5000). Antibodies were purchased from Cell Signaling Technology unless otherwise stated. Protein band intensity was quantified by ImageJ software.
+ Open protocol
+ Expand
7

Immunohistochemical Analysis of Signaling Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemistry was performed in paraffin-embedded serial sections using phospho-STAT3 (Santa Cruz), STAT3, phospho-Akt, Akt, phospho-ERK, ERK (Cell Signaling), and Ki67 (Biocare Medical, Concord, CA) antibodies, as described [30 (link)].
+ Open protocol
+ Expand
8

Adipose Tissue Protein Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hypothalami, epididymal fats, and liver tissues (n = 6/group) were isolated, and proteins extracted using the commercial Tissue Protein Extraction Reagents (T-PER, Pierce Biotechnology, Rockford, IL, USA). Equal amounts of proteins were resolved by SDS-PAGE, before being transferred to the polyvinylidine fluoride membrane. The membranes were blocked with 5% nonfat milk and incubated with primary antibodies, horseradish peroxidase-conjugated IgG, and enhanced chemiluminescence Western blotting reagents. The visualized signals were quantitated by a densitor meter. Primary antibodies used were: Akt, phospho-Akt, signal transducers and activators of transcription 3 (STAT3), phospho-STAT3, STAT6, phospho-STAT6, PRDM16, PGC-1α, UCP-1, CD68, CD206, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
+ Open protocol
+ Expand
9

Western Blot Analysis of Signaling Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Western blot analyses were performed following a standard procedure. Proteins were separated by SDS-PAGE and transferred onto nitrocellulose membranes. The membranes were incubated with the antibodies raised against phospho-S33/S37/T41-BCATENIN (Cell Signaling Technology [CST], #9561), phospho-S465/467-SMAD2 (CST, #3101), SMAD2/3 (CST, #3102), p-ERK (CST, #4370), ERK (CST, #9102), BCATENIN (BD Biosciences, C19220-050), phospho-STAT3 (Santa Cruz Biotechnology, sc-8059), and STAT3 (Santa Cruz, sc-482). Protein bands were visualized using ECL Prime Western Blotting Detection Reagent (GE Healthcare).
+ Open protocol
+ Expand
10

Synergistic Anticancer Effects of Selinexor and Sorafenib

Check if the same lab product or an alternative is used in the 5 most similar protocols
Selinexor was provided by Karyopharm Therapeutics (Newton, MA, USA). Sorafenib was purchased from Selleckchem (Houston, TX, USA). Their molecular structures are shown in Online Supplementary Figure S1. The antibodies against human phosphorylated (p)-p44/42 MAPK (ERK1/2)(Thr202/Tyr204), phospho-AKT(Ser473), phospho-FLT3(Tyr589/591), phospho-S6K(Ser240/244), AKT, S6K, Bcl-xL, C/EBPα, PU.1, STAT3, c-Myc and cleaved caspase-3 were purchased from Cell Signaling Technology (Danvers, MA, USA), against Bcl-2 from Dako (Carpinteria, CA, USA), against phospho-STAT5 A/B from Upstate (Lake Placid, NY, USA), against total STAT5A/B from R&D Systems Inc. (Minneapolis, MN, USA), against ERK2, FLT3, p53, IκB alpha, phospho-STAT3, and Mcl-1 from Santa Cruz Biotechnology (Santa Cruz, CA, USA), against Bim and Puma from CalBiochem (San Diego, CA, USA), against HIF1α from BD Biosciences (San Diego, CA, USA), and against phospho-IκB alpha (ser32/36) from Novus (Littleton, CO, USA). The anti-luciferase antibody was purchased from Promega (Madison, WI, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!